Medtronic plc — Director's Dealing 2019

Dec 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-12-24

Reporting Person: Kuntz Richard (SVP & Chief Medical & Science)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-24	Ordinary Shares	S	5067	$113.64	Disposed	74032	Direct
2019-12-24	Ordinary Shares	S	3019	$113.63	Disposed	71013	Direct
2019-12-24	Ordinary Shares	M	2404	$41.60	Acquired	73417	Direct
2019-12-24	Ordinary Shares	S	2404	$113.60	Disposed	71013	Direct
2019-12-24	Ordinary Shares	M	1808	$55.32	Acquired	72821	Direct
2019-12-24	Ordinary Shares	S	1808	$113.66	Disposed	71013	Direct
2019-12-24	Ordinary Shares	M	38558	$55.32	Acquired	109571	Direct
2019-12-24	Ordinary Shares	S	38558	$113.56	Disposed	71013	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-24	Stock Option (Right to Buy)	$41.60	M	2404	Disposed	2022-10-29	Ordinary Shares (2404)	Direct
2019-12-24	Stock Option (Right to Buy)	$55.32	M	1808	Disposed	2023-07-29	Ordinary Shares (1808)	Direct
2019-12-24	Stock Option (Right to Buy)	$55.32	M	38558	Disposed	2023-07-29	Ordinary Shares (38558)	Direct

Footnotes

F1: This balance increased by 283 shares due to exempt transactions such as dividend reinvestment.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $113.48 to $113.66, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.

F3: This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F4: This option to purchase 1,808 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,808 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F5: This option to purchase 38,558 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 38,558 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.